Advertisement
Screener

MUSTANG BIO, INC. (MBIO) Revenue, Net (Deprecated 2018-01-31)

MUSTANG BIO, INC. Revenue, Net (Deprecated 2018-01-31)

MUSTANG BIO, INC. (MBIO) reported Revenue, Net (Deprecated 2018-01-31) of $0 for the 3-month period ending 2017-12-31, per its 10-K filed 2018-03-29.

Discontinued › Income Statement › Revenue

us-gaap:SalesRevenueNet · last filed 2018-03-29

  • MUSTANG BIO, INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $0.00.
  • MUSTANG BIO, INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $0.00.
  • MUSTANG BIO, INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $0.00.
  • MUSTANG BIO, INC. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $0.00.
Period endRevenue, Net (Deprecated 2018-01-31) 1 monthRevenue, Net (Deprecated 2018-01-31) 3 monthRevenue, Net (Deprecated 2018-01-31) 6 monthRevenue, Net (Deprecated 2018-01-31) 9 monthRevenue, Net (Deprecated 2018-01-31) 12 month
2017-12-31$0.00
10-K · filed 2018-03-29
$0.00
derived: sum of 2 quarters · filed 2018-03-29
$0.00
derived: sum of 3 quarters · filed 2018-03-29
$0.00
derived: sum of 4 quarters · filed 2018-03-29
2017-09-30$0.00
10-K · filed 2018-03-29
$0.00
derived: sum of 2 quarters · filed 2018-03-29
$0.00
derived: sum of 3 quarters · filed 2018-03-29
$0.00
derived: sum of 4 quarters · filed 2018-03-29
2017-06-30$0.00
10-K · filed 2018-03-29
$0.00
derived: sum of 2 quarters · filed 2018-03-29
$0.00
derived: sum of 3 quarters · filed 2018-03-29
$0.00
derived: sum of 4 quarters · filed 2018-03-29
2017-03-31$0.00
10-K · filed 2018-03-29
$0.00
derived: sum of 2 quarters · filed 2018-03-29
$0.00
derived: sum of 3 quarters · filed 2018-03-29
$0.00
derived: sum of 4 quarters · filed 2018-03-29
2016-12-31$0.00
10-K · filed 2018-03-29
$0.00
derived: sum of 2 quarters · filed 2018-03-29
$0.00
derived: sum of 3 quarters · filed 2018-03-29
$0.00
derived: sum of 4 quarters · filed 2018-03-29
2016-09-30$0.00
10-K · filed 2018-03-29
$0.00
derived: sum of 2 quarters · filed 2018-03-29
$0.00
derived: sum of 3 quarters · filed 2018-03-29
$0.00
derived: sum of 4 quarters · filed 2018-03-29
2016-06-30$0.00
10-K · filed 2018-03-29
$0.00
derived: sum of 2 quarters · filed 2018-03-29
$0.00
derived: sum of 3 quarters · filed 2018-03-29
$0.00
derived: sum of 4 quarters · filed 2018-03-29
2016-03-31$0.00
10-K · filed 2018-03-29
$0.00
derived: sum of 2 quarters · filed 2018-03-29
$0.00
derived: sum of 3 quarters · filed 2018-03-29
$0.00
derived: sum of 4 quarters · filed 2018-03-29
2015-12-31$0.00
10-K · filed 2017-03-31
$0.00
derived: sum of 2 quarters · filed 2017-03-31
$0.00
derived: sum of 3 quarters · filed 2017-03-31
2015-09-30$0.00
10-K · filed 2017-03-31
$0.00
derived: sum of 2 quarters · filed 2017-03-31
2015-06-30$0.00
10-K · filed 2017-03-31
2015-03-31$0.00
10-K · filed 2017-03-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Tempest Therapeutics, Inc. (TPST)United States$0.013B
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
BIOVIE INC. (BIVI)United States$0.012B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B